Should we routinely measure a proxy for insulin resistance as well as improve our modelling techniques to better predict the likelihood of coronary heart disease in people with type 2 diabetes? For debate.
Evans
Marc
M
Department of Endocrinology, Diabetes and Metabolism, University of Wales College of Medicine, Cardiff, Wales, UK.
McEwan
Phil
P
Peters
John R
JR
Currie
Craig J
CJ
D003327:Coronary Disease / Q000517:prevention & control*; D003924:Diabetes Mellitus, Type 2 / Q000517:prevention & control*; D003925:Diabetic Angiopathies / Q000517:prevention & control*; D006801:Humans; D007333:Insulin Resistance / Q000502:physiology*; D008955:Models, Cardiovascular; D012044:Regression Analysis; D018570:Risk Assessment; D012307:Risk Factors